Zanidatamab Combo Has Meaningful Activity in HER2+ Gastroesophageal Cancer
Confirmatory data may support zanidatamab as an advancement in the treatment of HER2-positive advanced gastroesophageal adenocarcinoma.
Unveiling Advances in GU Cancers: Insights from Oncology Decoded
Dive into the latest in genitourinary oncology with "Oncology Decoded," featuring discussions on KEYNOTE-564 with RCC.
Current Use and Future Directions of Artificial Intelligence in Hematology/Oncology
As AI revolutionizes cancer care by enhancing diagnosis, treatment, and clinical trial matching, it may lead to improved patient outcomes and streamlined workflows.
Harnessing PIPAC to Improve Outcomes in Peritoneal Carcinomatosis
Benjamin Golas, MD, discusses how the use of PIPAC may work in conjunction with systemic chemotherapy for those with peritoneal carcinomatosis.
Obrixtamig Plus Topotecan Shows Tolerability, Efficacy in Advanced ES-SCLC
The frequency and severity of adverse effects for the combination were consistent with expected safety findings for each individual agent.
Diagnosing and Treating Patients With Epithelioid Sarcoma
Experts discussed diagnosing and treating epithelioid sarcoma, emphasizing the importance of clinical history and the role of multiple multidisciplinary clinicians in care.
